Min Jun (@MinJun____) profile picture

Min Jun

@MinJun____

Scientia Associate Professor and Program Lead, The George Institute for Global Health, Faculty of Medicine, UNSW Sydney; kidney epidemiology

 Sydney, New South Wales
Joined May 2018
  • Tweets195
  • Following277
  • Followers207
4Media
Photo by Min Jun (@MinJun____)Photo by Min Jun (@MinJun____)Photo by Min Jun (@MinJun____)Photo by Min Jun (@MinJun____)
Min Jun retweeted
NHMRC (@nhmrc) profile picture
NHMRC
@nhmrc10 Mar 2024
Dr Sradha Kotwal of @UNSW and @georgeinstitute has developed the Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE), aiming to identify an effective drug to prevent CKD progression #KidneyHealthForAll #WorldKidneyDay
Image from NHMRC (@nhmrc)
4
11
1,726
Come work with us! We have an exciting opening for a biostatistician to join the @georgeinstitute's Renal & Metabolic Division Great opportunity to work on large-scale cardiorenal randomised trials and routinely collected data applynow.net.au/jobs/GEORGE6… DM me for details
Image from Brendon Neuen (@brendonneuen)
5
13
1,864
"I wanted to look into an area of research that had the biggest impact on society." Hear more from Nelson about his work on cardiovascular prevention and his long-term goals for his future work via @heartfoundation: buff.ly/3IaQNjK
1
1
311
Min Jun retweeted
AJKD (@AJKDonline) profile picture
AJKD@AJKDonline7 Feb 2024
Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis buff.ly/3Q22tca @_jeffreyha @DearbhlaKelly4 @brendonneuen @VladoPerkovic @MinJun____ @badves @georgeinstitute @UNSWMedicine #VisualAbstract
Image from AJKD (@AJKDonline)
11
11
2,343
The Prevalence of #ChronicKidneyDisease in Australian #PrimaryCare: Analysis of a National General Practice Dataset #VisualAbstract by @jmteakell kireports.org/article/S2468-… @MinJun____ @brendonneuen @SradhaKotwal @Badves @davidpeiris @jardine_meg @VladoPerkovic @georgeinstitute
Image from KIReports (@KIReports)
4
11
1,093
Improved uptake of SGLT2i in people with CKD has the potential to substantially reduce the incidence of kidney failure in Australia Implementation now critical to realising these population level benefits Our new paper #openaccess in @LancetRH_WPac thelancet.com/journals/lanwp…
Image from Brendon Neuen (@brendonneuen)
2
30
3
78
12,492
Latest granular data on CKD trends in Australia CKD is common & increasing year on year UACR testing remains abysmally low Major opportunities for early detection & treatment to prevent cardiovascular & kidney disease Led by @MinJun____ in @KIReports: kireports.org/article/S2468-…
Image from Brendon Neuen (@brendonneuen)
2
10
1
47
5,747
#ICYMI, check out this #ICESKDT study by @_jeffreyha and team that focused on determining the benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation in patients with #CKD. pubmed.ncbi.nlm.nih.gov/3749… @ICESOntario @MinJun____ 1/
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A...

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A...

This real-world study involved a large cohort of 55,568 adults with atrial fibrillation from 5 jurisdictions across Australia and Canada. It showed that the favorable safety (bleeding) and effectiv...

pubmed.ncbi.nlm.nih.gov
1
7
12
1,868
Congratulations to @SradhaKotwal for securing @nhmrc funding to test new treatments in people with #ChronicKidneyDisease at trial centres in Australia & other countries. 🔗bit.ly/3KksTE9
Image from The George Institute for Global Health (@georgeinstitute)
2
9
2
27
9,154
The largest & most comprehensive analysis of the association between SGLT2i, blood pressure variability & cardiorenal outcomes While SGLT2i reduce BP, they have little to no effect on BP variability New #openaccess in @JAHA_AHA led by @Fletcher_RA ahajournals.org/doi/full/10.…
Image from Brendon Neuen (@brendonneuen)
Image from Brendon Neuen (@brendonneuen)
Image from Brendon Neuen (@brendonneuen)
2
25
1
62
7,759
Sharing this real-world study 🇦🇺🇨🇦showing favorable⚖️ safety🩸& effectiveness of Riva vs Warfarin across broad range of kidney fn with some imp safety data in those with greatly ⏬ kidney fn @MinJun____ @georgeinstitute @UNSWMedicine doi.org/10.1016/j.xkme.2023.…
SevenOaksCDIC (@SevenOaksCDIC) profile pictureSevenOaksCDIC@SevenOaksCDIC18 May 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia 🇦🇺 and Canada 🇨🇦. @KidneyMed ➡️ bit.ly/3MD9wYl
Image from SevenOaksCDIC (@SevenOaksCDIC)
Image from SevenOaksCDIC (@SevenOaksCDIC)
4
8
925
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia 🇦🇺 and Canada 🇨🇦. @KidneyMed ➡️ bit.ly/3MD9wYl
Image from SevenOaksCDIC (@SevenOaksCDIC)
Image from SevenOaksCDIC (@SevenOaksCDIC)
7
1
11
2,093
Congratulations to Drs Majed Al Jeraisy, Mohammed Tawhari and @Ahmed_Shaman from @kaimrc_ksa for enrolling their FIRST three patients in TRACK. We welcome Saudi Arabia 🇸🇦 to the TRACK trial.
2
4
14
Do multifaceted interventions or care bundles reduce #Dialysis catheter related bloodstream infections? Our researchers @SradhaKotwal and team have published ✍️imp new findings from their @reducction trial today in the @bmj_latest: ▶️bmj.com/content/377/bmj-2021…
Image from The George Institute for Global Health (@georgeinstitute)
10
1
18
Replying to @reducction @SradhaKotwal @sarah_scoggan @NephMcDonald @georgeinstitute
Also provides impt insights into the scale of Hawthorne effect in such evidence implementation studies
1
3
Fantastic opportunity to work on practice changing trials and big data with collaborative colleagues, and to make a global impact - join us!! @GLDiTanna @MinJun____ @ArnottClare @SradhaKotwal @Badves @alta_schutte
The George Institute for Global Health (@georgeinstitute) profile pictureThe George Institute for Global Health@georgeinstitute17 Dec 2021
Expressions of Interest invited from biostatisticians across all levels of experience to join our growing Biostatistics team! Check out details: georgeinstitute.org/careers/… and connect with @GLDiTanna!
Image from The George Institute for Global Health (@georgeinstitute)
2
7
Fantastic opportunity at my new workplace - join us @UNSWMedicine
This Post is from an account that no longer exists. Learn more
2
5
Congratulations @SradhaKotwal! @ANZSN #ANZSNASM
ANZSN (@ANZSN) profile pictureANZSN@ANZSN1 Sep 2021
Congratulations to Sradha Kotwal, winner of the KIDNEY HEALTH AUSTRALIA (KHA) CLINICAL SCIENCE AWARD #ANZSNASM @SradhaKotwal @KidneyHealth @KarenDwyer12
Image from ANZSN (@ANZSN)
2
6
1
18
Congratulations @drmanishasahay for randomising the 100th patient in @TRACK_trial Top recruiters are Hospital Tuanku Ja'afar, Seremban Hospital Raja Permaisuri Bainun, Ipoh Hospital Canselor Tuanku Muhriz Hospital Kajang University of Malaysia Medical Centre 1/3
Image from The TRACK Trial (@TRACK_trial)
2
3
12
This is by far the most important piece of research I have been involved in... given the large-scale potential of the impact. @MaoyiT @WASHSALT @ResolveTSL @DrTomFrieden
The George Institute for Global Health (@georgeinstitute) profile pictureThe George Institute for Global Health@georgeinstitute29 Aug 2021
#LessSalt #SaltSubstitutes Ground-breaking study shows salt substitutes significantly reduce risk of #stroke and death compared to regular salt. Find out more: bit.ly/3jr22cx
Image from The George Institute for Global Health (@georgeinstitute)
4
31
3
100
Load more